Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
20.75
-2.02 (-8.87%)
At close: May 12, 2025, 4:00 PM
20.75
0.00 (0.00%)
After-hours: May 12, 2025, 4:00 PM EDT
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $230.18 million as of May 12, 2025.
Market Cap
230.18M
Enterprise Value
157.09M
1-Year Change
n/a
Ranking
Category
Stock Price
$20.75
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $230.18M, an increase of 59.88%. That is a compound annual growth rate of 228.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 250.90M | 86.32% |
| Dec 31, 2024 | 134.66M | -6.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |